AI Verdict
REGN has stronger fundamentals based on our AI analysis.
REGN vs SYK Fundamental Comparison
| Metric | REGN | SYK |
|---|---|---|
| Revenue | $3.6B | $6.0B |
| Net Income | $727.2M | $745.0M |
| Net Margin | 20.2% | 12.4% |
| ROE | 2.3% | 3.2% |
| ROA | 1.8% | 1.6% |
| Current Ratio | 3.57x | 2.11x |
| Debt/Equity | 0.06x | 0.62x |
| EPS | $6.75 | $1.93 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
REGN vs SYK: Frequently Asked Questions
Is REGN or SYK the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. REGN is graded A (80% confidence) while SYK is graded A (77% confidence). This is not investment advice.
How does REGN compare to SYK fundamentally?
REGENERON PHARMACEUTICALS, INC. has ROE of 2.3% vs STRYKER CORP's 3.2%. Net margins are 20.2% vs 12.4% respectively.
Which stock pays higher dividends, REGN or SYK?
REGN has a dividend yield of N/A or no dividend while SYK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in REGN or SYK for long term?
For long-term investing, consider that REGN has a A grade with 80% confidence, while SYK has a A grade with 77% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about REGN vs SYK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REGN vs SYK, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.